Healthcare Sector Stocks
The Healthcare sector has a total of 1050 stocks, with a combined market cap of $9.88 trillion, total revenue of $4.73 trillion and a weighted average PE ratio of 46.91.
Market Cap
9.88T
Revenue
4.73T
Profits
210.69B
PE Ratio
46.91
Profit Margin
4.46%
Dividend Yield
0.38%
1050 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.22T | -3.76% | 4,888,506 | 86.46B |
| 2 | JNJ | Johnson & Johnson | 655.56B | -1.45% | 9,661,399 | 99.34B |
| 3 | ABBV | AbbVie Inc. | 509.50B | -2.24% | 7,970,773 | 66.01B |
| 4 | MRK | Merck & Co., Inc. | 362.24B | -2.27% | 11,547,650 | 67.38B |
| 5 | UNH | UnitedHealth Group Incorporated | 354.57B | -3.34% | 6,890,936 | 450.06B |
| 6 | NVS | Novartis AG | 310.78B | -1.85% | 2,440,139 | 57.36B |
| 7 | AZN | AstraZeneca PLC | 293.41B | -1.14% | 4,842,576 | 62.38B |
| 8 | TMO | Thermo Fisher Scientific Inc. | 250.82B | -4.14% | 2,835,882 | 47.35B |
| 9 | AMGN | Amgen Inc. | 248.97B | -3.80% | 4,171,103 | 38.90B |
| 10 | GILD | Gilead Sciences, Inc. | 207.84B | -3.96% | 11,510,566 | 30.99B |
| 11 | ABT | Abbott Laboratories | 196.75B | -1.65% | 10,285,272 | 48.23B |
| 12 | NVO | Novo Nordisk A/S | 179.56B | -4.46% | 18,499,394 | 50.70B |
| 13 | PFE | Pfizer Inc. | 170.31B | -2.96% | 53,062,428 | 63.62B |
| 14 | ISRG | Intuitive Surgical, Inc. | 162.41B | -2.82% | 4,742,359 | 11.58B |
| 15 | DHR | Danaher Corporation | 159.24B | -3.66% | 5,138,042 | 25.61B |
| 16 | VRTX | Vertex Pharmaceuticals Incorporated | 137.54B | -1.19% | 2,514,805 | 12.95B |
| 17 | BMY | Bristol-Myers Squibb Company | 129.04B | -1.65% | 9,026,833 | 50.03B |
| 18 | MDT | Medtronic plc | 128.34B | -0.11% | 11,648,114 | 37.54B |
| 19 | SYK | Stryker Corporation | 127.56B | -1.35% | 4,459,500 | 26.30B |
| 20 | MCK | McKesson Corporation | 123.77B | 0.24% | 1,285,779 | 418.79B |
| 21 | SNY | Sanofi | 113.65B | -1.18% | 7,119,458 | 57.89B |
| 22 | HCA | HCA Healthcare, Inc. | 106.01B | -0.63% | 1,657,614 | 78.70B |
| 23 | CVS | CVS Health Corporation | 104.06B | 1.71% | 19,930,576 | 418.16B |
| 24 | GSK | GSK plc | 102.07B | -1.45% | 3,059,631 | 44.53B |
| 25 | MRNA | Moderna, Inc. | 96.40B | -6.55% | 12,101,303 | 2.23B |
| 26 | ELV | Elevance Health, Inc. | 93.34B | -0.50% | 2,113,759 | 201.83B |
| 27 | REGN | Regeneron Pharmaceuticals, Inc. | 90.60B | -2.98% | 1,420,582 | 16.90B |
| 28 | CI | The Cigna Group | 79.66B | -1.29% | 2,764,069 | 286.32B |
| 29 | TAK | Takeda Pharmaceutical Company Limited | 69.67B | 0.62% | 4,735,016 | 29.86B |
| 30 | COR | Cencora, Inc. | 64.82B | -4.05% | 2,485,452 | 337.40B |
| 31 | BSX | Boston Scientific Corporation | 64.70B | -2.58% | 22,492,479 | 21.07B |
| 32 | CAH | Cardinal Health, Inc. | 62.02B | 2.25% | 2,994,424 | 257.75B |
| 33 | BDX | Becton, Dickinson and Company | 58.17B | 2.08% | 3,991,907 | 19.46B |
| 34 | EW | Edwards Lifesciences Corporation | 57.97B | 1.46% | 9,233,947 | 6.67B |
| 35 | ARGX | argenx SE | 57.24B | -3.93% | 399,745 | 5.92B |
| 36 | IDXX | IDEXX Laboratories, Inc. | 52.84B | -3.99% | 882,920 | 4.66B |
| 37 | NTRA | Natera, Inc. | 52.43B | -6.97% | 3,239,936 | 2.91B |
| 38 | MDLN | Medline Inc. | 52.30B | -1.46% | 14,245,797 | 30.68B |
| 39 | VEEV | Veeva Systems Inc. | 50.21B | -0.17% | 2,151,856 | 3.46B |
| 40 | HUM | Humana Inc. | 49.45B | -1.35% | 1,362,579 | 145.68B |
| 41 | TEVA | Teva Pharmaceutical Industries Limited | 48.75B | -0.17% | 13,709,667 | 17.23B |
| 42 | A | Agilent Technologies, Inc. | 48.43B | -3.04% | 2,698,858 | 7.37B |
| 43 | WAT | Waters Corporation | 44.51B | -3.11% | 1,149,806 | 5.61B |
| 44 | ONC | BeOne Medicines AG | 44.03B | 2.51% | 964,250 | 6.61B |
| 45 | IQV | IQVIA Holdings Inc. | 43.65B | 0.41% | 1,738,217 | 17.31B |
| 46 | HLN | Haleon plc | 40.43B | -0.87% | 38,366,776 | 14.80B |
| 47 | RPRX | Royalty Pharma plc | 38.76B | 0.01% | 4,900,587 | 2.62B |
| 48 | RVMD | Revolution Medicines, Inc. | 38.08B | -11.04% | 7,815,665 | 197.56M |
| 49 | GEHC | GE HealthCare Technologies Inc. | 37.87B | -2.40% | 6,290,265 | 21.64B |
| 50 | ALC | Alcon Inc. | 37.23B | -0.98% | 2,633,145 | 10.86B |
| 51 | CNC | Centene Corporation | 36.72B | -2.42% | 7,700,083 | 180.41B |
| 52 | BIIB | Biogen Inc. | 36.06B | -4.14% | 1,221,913 | 10.30B |
| 53 | ZTS | Zoetis Inc. | 33.93B | -7.95% | 10,087,804 | 9.52B |
| 54 | RMD | ResMed Inc. | 33.66B | -0.50% | 1,695,459 | 5.73B |
| 55 | MTD | Mettler-Toledo International Inc. | 33.64B | -2.56% | 294,572 | 4.20B |
| 56 | DXCM | DexCom, Inc. | 31.50B | -4.54% | 4,970,679 | 5.10B |
| 57 | ILMN | Illumina, Inc. | 31.45B | -8.18% | 4,243,322 | 4.54B |
| 58 | GMAB | Genmab A/S | 31.20B | -4.32% | 4,406,963 | 4.30B |
| 59 | PHG | Koninklijke Philips N.V. | 30.18B | -1.77% | 3,190,992 | 20.16B |
| 60 | LH | Labcorp Holdings Inc. | 29.50B | -1.22% | 775,272 | 14.59B |
| 61 | DGX | Quest Diagnostics Incorporated | 28.03B | -0.37% | 969,317 | 11.84B |
| 62 | WST | West Pharmaceutical Services, Inc. | 27.34B | -3.99% | 872,910 | 3.40B |
| 63 | ROIV | Roivant Sciences Ltd. | 26.45B | -4.21% | 10,195,182 | 7.53M |
| 64 | STE | STERIS plc | 24.78B | 2.50% | 1,652,652 | 6.17B |
| 65 | UTHR | United Therapeutics Corporation | 24.09B | -7.03% | 620,278 | 3.19B |
| 66 | INCY | Incyte Corporation | 24.05B | -3.94% | 1,602,229 | 6.01B |
| 67 | INSM | Insmed Incorporated | 23.86B | -1.13% | 2,618,614 | 1.52B |
| 68 | THC | Tenet Healthcare Corporation | 22.80B | -1.98% | 1,068,706 | 22.15B |
| 69 | VTRS | Viatris Inc. | 21.79B | -1.30% | 11,934,707 | 14.73B |
| 70 | BNTX | BioNTech SE | 21.29B | -5.34% | 1,191,524 | 2.75B |
| 71 | ALNY | Alnylam Pharmaceuticals, Inc. | 20.98B | -2.74% | 3,317,048 | 5.01B |
| 72 | GH | Guardant Health, Inc. | 20.59B | -8.99% | 4,085,287 | 1.28B |
| 73 | ZBH | Zimmer Biomet Holdings, Inc. | 20.22B | -3.00% | 3,623,766 | 8.57B |
| 74 | MEDP | Medpace Holdings, Inc. | 17.76B | -3.32% | 316,233 | 2.84B |
| 75 | RVTY | Revvity, Inc. | 16.83B | -5.39% | 2,295,196 | 2.94B |
| 76 | EXEL | Exelixis, Inc. | 16.77B | -5.55% | 4,605,298 | 2.50B |
| 77 | ASND | Ascendis Pharma A/S | 16.64B | -1.74% | 558,133 | 1.20B |
| 78 | NBIX | Neurocrine Biosciences, Inc. | 16.17B | -3.79% | 1,484,550 | 3.70B |
| 79 | ICLR | ICON Public Limited Company | 15.11B | -0.72% | 1,476,137 | 8.23B |
| 80 | CRL | Charles River Laboratories International, Inc. | 15.00B | -4.07% | 1,660,943 | 3.98B |
| 81 | SOLV | Solventum Corporation | 14.84B | -2.43% | 1,880,738 | 8.16B |
| 82 | JAZZ | Jazz Pharmaceuticals plc | 14.59B | -3.13% | 671,000 | 4.72B |
| 83 | BBIO | BridgeBio Pharma, Inc. | 14.47B | -4.65% | 3,385,502 | 945.54M |
| 84 | HALO | Halozyme Therapeutics, Inc. | 13.96B | -5.66% | 2,898,871 | 1.66B |
| 85 | EHC | Encompass Health Corporation | 13.86B | 0.17% | 1,560,580 | 6.34B |
| 86 | BTSG | BrightSpring Health Services, Inc. | 13.72B | -5.64% | 3,813,903 | 15.25B |
| 87 | SNN | Smith & Nephew plc | 13.34B | -1.39% | 2,818,362 | 6.30B |
| 88 | BAX | Baxter International Inc. | 13.27B | -3.21% | 10,102,998 | 11.61B |
| 89 | GKOS | Glaukos Corporation | 13.02B | -10.83% | 2,042,313 | 690.33M |
| 90 | TEM | Tempus AI, Inc. | 12.85B | -6.85% | 10,019,089 | 1.51B |
| 91 | PEN | Penumbra, Inc. | 12.66B | -0.42% | 310,538 | 1.56B |
| 92 | FMS | Fresenius Medical Care AG | 12.32B | 2.03% | 1,471,036 | 22.12B |
| 93 | DVA | DaVita Inc. | 12.26B | 1.12% | 633,522 | 14.17B |
| 94 | COO | The Cooper Companies, Inc. | 12.08B | -1.41% | 2,383,429 | 4.24B |
| 95 | RDY | Dr. Reddy's Laboratories Limited | 12.00B | -1.62% | 4,808,229 | 3.44B |
| 96 | ELAN | Elanco Animal Health Incorporated | 11.83B | -6.44% | 6,712,168 | 5.02B |
| 97 | UHS | Universal Health Services, Inc. | 11.70B | 1.08% | 1,316,063 | 18.35B |
| 98 | TECH | Bio-Techne Corporation | 11.39B | -0.10% | 4,516,617 | 1.22B |
| 99 | SMMT | Summit Therapeutics Inc. | 11.35B | -12.24% | 5,970,613 | - |
| 100 | MOH | Molina Healthcare, Inc. | 11.29B | -4.32% | 928,209 | 42.08B |
| 101 | ALGN | Align Technology, Inc. | 11.23B | -3.35% | 1,387,873 | 4.16B |
| 102 | KYMR | Kymera Therapeutics, Inc. | 10.94B | -5.97% | 1,735,895 | 102.24M |
| 103 | GMED | Globus Medical, Inc. | 10.93B | -6.50% | 4,093,705 | 3.14B |
| 104 | BMRN | BioMarin Pharmaceutical Inc. | 10.87B | -1.77% | 2,166,188 | 3.66B |
| 105 | PODD | Insulet Corporation | 10.83B | -5.39% | 1,322,278 | 3.19B |
| 106 | RGEN | Repligen Corporation | 10.77B | -5.45% | 1,383,539 | 805.61M |
| 107 | ENSG | The Ensign Group, Inc. | 10.55B | -3.14% | 398,112 | 5.67B |
| 108 | QGEN | Qiagen N.V. | 10.50B | 0.06% | 4,627,363 | 2.12B |
| 109 | AVTR | Avantor, Inc. | 10.26B | -3.26% | 7,464,739 | 6.64B |
| 110 | OSCR | Oscar Health, Inc. | 10.23B | -5.71% | 11,560,585 | 17.47B |
| 111 | BIO | Bio-Rad Laboratories, Inc. | 9.92B | -2.89% | 433,889 | 2.59B |
| 112 | PCVX | Vaxcyte, Inc. | 9.75B | -5.72% | 1,836,469 | - |
| 113 | HSIC | Henry Schein, Inc. | 9.43B | -3.32% | 2,100,442 | 13.73B |
| 114 | HNGE | Hinge Health, Inc. | 9.36B | -4.05% | 2,653,954 | 800.82M |
| 115 | MDGL | Madrigal Pharmaceuticals, Inc. | 9.29B | -0.08% | 859,764 | 1.43B |
| 116 | SYRE | Spyre Therapeutics, Inc. | 9.17B | -2.47% | 1,161,303 | - |
| 117 | ATR | AptarGroup, Inc. | 9.13B | -1.92% | 693,450 | 3.99B |
| 118 | KRYS | Krystal Biotech, Inc. | 8.90B | -3.41% | 401,608 | 470.03M |
| 119 | BRKR | Bruker Corporation | 8.85B | -8.98% | 3,306,393 | 3.51B |
| 120 | PTGX | Protagonist Therapeutics, Inc. | 8.75B | -5.66% | 585,963 | 551.69M |
| 121 | HQY | HealthEquity, Inc. | 8.56B | -4.94% | 1,383,391 | 1.36B |
| 122 | IBRX | ImmunityBio, Inc. | 8.49B | -10.30% | 12,583,843 | 165.79M |
| 123 | TGTX | TG Therapeutics, Inc. | 8.22B | -5.92% | 2,114,415 | 799.54M |
| 124 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.12B | -6.80% | 1,807,809 | 669.50M |
| 125 | PACS | PACS Group, Inc. | 7.97B | -0.12% | 1,563,330 | 5.71B |
| 126 | CORT | Corcept Therapeutics Incorporated | 7.84B | -9.58% | 1,510,391 | 963.65M |
| 127 | CYTK | Cytokinetics, Incorporated | 7.72B | -12.66% | 6,782,997 | 113.29M |
| 128 | ABVX | ABIVAX Société Anonyme | 7.60B | -5.94% | 1,236,506 | 5.33M |
| 129 | TXG | 10x Genomics, Inc. | 7.56B | -14.01% | 5,978,554 | 618.58M |
| 130 | TWST | Twist Bioscience Corporation | 7.56B | -15.41% | 3,095,902 | 431.80M |
| 131 | GRFS | Grifols, S.A. | 7.53B | -1.74% | 762,788 | 8.63B |
| 132 | ALKS | Alkermes plc | 7.48B | -2.94% | 1,945,565 | 1.75B |
| 133 | CAI | Caris Life Sciences, Inc. | 7.47B | -21.64% | 7,834,399 | 1.05B |
| 134 | PRAX | Praxis Precision Medicines, Inc. | 7.33B | -7.80% | 339,882 | 7.46M |
| 135 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.28B | -5.11% | 6,405,361 | 280.75M |
| 136 | BLCO | Bausch + Lomb Corporation | 7.12B | -3.30% | 699,442 | 5.42B |
| 137 | KNSA | Kiniksa Pharmaceuticals International, plc | 6.94B | -8.09% | 962,264 | 945.96M |
| 138 | CHE | Chemed Corporation | 6.92B | -2.71% | 143,403 | 2.66B |
| 139 | AXSM | Axsome Therapeutics, Inc. | 6.83B | -5.26% | 1,110,157 | 865.27M |
| 140 | AMRX | Amneal Pharmaceuticals, Inc. | 6.77B | -2.51% | 4,950,780 | 3.20B |
| 141 | LNTH | Lantheus Holdings, Inc. | 6.57B | -0.44% | 1,235,664 | 1.56B |
| 142 | IONS | Ionis Pharmaceuticals, Inc. | 6.45B | -3.36% | 2,977,598 | 874.09M |
| 143 | TFX | Teleflex Incorporated | 6.45B | 1.52% | 1,417,534 | 2.25B |
| 144 | ORKA | Oruka Therapeutics, Inc. | 6.36B | -5.32% | 848,433 | - |
| 145 | RDNT | RadNet, Inc. | 6.14B | -2.80% | 1,052,496 | 2.27B |
| 146 | MIRM | Mirum Pharmaceuticals, Inc. | 6.11B | -3.54% | 872,740 | 670.78M |
| 147 | LGND | Ligand Pharmaceuticals Incorporated | 5.98B | -5.42% | 247,847 | 253.83M |
| 148 | DOCS | Doximity, Inc. | 5.91B | -4.30% | 2,661,414 | 661.58M |
| 149 | IMVT | Immunovant, Inc. | 5.86B | -5.05% | 1,123,050 | - |
| 150 | BLTE | Belite Bio, Inc | 5.77B | -7.03% | 223,800 | - |
| 151 | CGON | CG Oncology, Inc. | 5.74B | -4.30% | 931,989 | 6.23M |
| 152 | KOD | Kodiak Sciences Inc. | 5.71B | -7.60% | 1,105,169 | - |
| 153 | HAE | Haemonetics Corporation | 5.65B | -2.60% | 1,302,143 | 1.38B |
| 154 | HIMS | Hims & Hers Health, Inc. | 5.61B | -9.75% | 17,589,762 | 2.58B |
| 155 | WAY | Waystar Holding Corp. | 5.56B | -2.73% | 2,383,615 | 1.26B |
| 156 | SUPN | Supernus Pharmaceuticals, Inc. | 5.55B | -5.21% | 6,085,022 | 1.37B |
| 157 | SRRK | Scholar Rock Holding Corporation | 5.54B | -1.28% | 1,457,631 | - |
| 158 | PTCT | PTC Therapeutics, Inc. | 5.49B | -4.78% | 1,241,920 | 1.16B |
| 159 | CON | Concentra Group Holdings Parent, Inc. | 5.37B | -3.24% | 1,897,093 | 2.29B |
| 160 | MANE | Veradermics, Incorporated | 5.37B | -5.79% | 788,212 | - |
| 161 | MMSI | Merit Medical Systems, Inc. | 5.37B | -1.11% | 940,709 | 1.61B |
| 162 | GRAL | GRAIL, Inc. | 5.33B | -17.08% | 2,162,754 | 166.60M |
| 163 | BLLN | BillionToOne, Inc. | 5.30B | -1.32% | 1,686,628 | 436.87M |
| 164 | LIVN | LivaNova PLC | 5.19B | -3.24% | 1,244,053 | 1.51B |
| 165 | COGT | Cogent Biosciences, Inc. | 5.13B | -6.07% | 2,728,580 | - |
| 166 | LFST | LifeStance Health Group, Inc. | 5.13B | -5.49% | 11,052,936 | 1.68B |
| 167 | MMED | MiniMed Group, Inc. | 5.11B | -5.88% | 10,056,135 | 3.22B |
| 168 | OPCH | Option Care Health, Inc. | 4.72B | -0.47% | 4,762,192 | 5.75B |
| 169 | CRSP | CRISPR Therapeutics AG | 4.71B | -6.22% | 2,154,680 | 25.17M |
| 170 | TVTX | Travere Therapeutics, Inc. | 4.69B | -6.77% | 2,196,185 | 651.03M |
| 171 | DNTH | Dianthus Therapeutics, Inc. | 4.64B | -3.26% | 1,062,811 | 2.72M |
| 172 | ERAS | Erasca, Inc. | 4.64B | -11.00% | 6,700,484 | - |
| 173 | SHC | Sotera Health Company | 4.53B | -3.17% | 3,147,353 | 1.23B |
| 174 | HTFL | HeartFlow, Inc. | 4.52B | -8.17% | 2,149,267 | 212.07M |
| 175 | LEGN | Legend Biotech Corporation | 4.37B | -1.01% | 3,236,450 | 1.27B |
| 176 | ADPT | Adaptive Biotechnologies Corporation | 4.34B | 0.45% | 4,048,180 | 298.01M |
| 177 | ITGR | Integer Holdings Corporation | 4.31B | 0.09% | 1,012,966 | 1.83B |
| 178 | IRTC | iRhythm Holdings, Inc. | 4.29B | -2.84% | 803,423 | 825.34M |
| 179 | EWTX | Edgewise Therapeutics, Inc. | 4.22B | 3.57% | 5,225,239 | - |
| 180 | ICUI | ICU Medical, Inc. | 4.19B | -2.88% | 530,222 | 2.16B |
| 181 | DFTX | Definium Therapeutics, Inc. | 4.08B | -7.16% | 1,919,474 | - |
| 182 | CDNA | CareDx, Inc. | 4.01B | -11.10% | 2,066,113 | 497.40M |
| 183 | NVST | Envista Holdings Corporation | 4.00B | -8.20% | 5,497,281 | 2.88B |
| 184 | LQDA | Liquidia Corporation | 3.98B | -6.10% | 2,144,425 | 450.91M |
| 185 | PLSE | Pulse Biosciences, Inc. | 3.79B | -6.99% | 535,773 | 1.19M |
| 186 | RLAY | Relay Therapeutics, Inc. | 3.73B | -5.71% | 4,728,164 | 10.35M |
| 187 | ACAD | Acadia Pharmaceuticals Inc. | 3.66B | -1.07% | 6,032,324 | 1.20B |
| 188 | XENE | Xenon Pharmaceuticals Inc. | 3.65B | -3.85% | 1,037,994 | 7.50M |
| 189 | OGN | Organon & Co. | 3.62B | -0.29% | 3,756,466 | 6.10B |
| 190 | STVN | Stevanato Group S.p.A. | 3.61B | -1.71% | 4,493,929 | 1.42B |
| 191 | ABCL | AbCellera Biologics Inc. | 3.61B | -9.36% | 4,158,840 | 66.17M |
| 192 | TNGX | Tango Therapeutics, Inc. | 3.52B | -9.97% | 3,413,304 | 53.81M |
| 193 | IOVA | Iovance Biotherapeutics, Inc. | 3.51B | -11.03% | 23,430,210 | 378.98M |
| 194 | IRON | Disc Medicine, Inc. | 3.48B | -5.78% | 933,344 | - |
| 195 | AMLX | Amylyx Pharmaceuticals, Inc. | 3.47B | -6.05% | 2,211,099 | -665.00K |
| 196 | PBLS | Parabilis Medicines, Inc. | 3.44B | -8.17% | 922,417 | 148.00K |
| 197 | ARQT | Arcutis Biotherapeutics, Inc. | 3.41B | -20.70% | 7,608,786 | 508.68M |
| 198 | TLX | Telix Pharmaceuticals Limited | 3.33B | -2.59% | 329,360 | 890.79M |
| 199 | TARS | Tarsus Pharmaceuticals, Inc. | 3.33B | -2.24% | 1,718,159 | 682.20M |
| 200 | VKTX | Viking Therapeutics, Inc. | 3.29B | -7.79% | 4,853,993 | - |
| 201 | ELVN | Enliven Therapeutics, Inc. | 3.28B | -5.21% | 1,611,473 | - |
| 202 | NHC | National HealthCare Corporation | 3.25B | -2.25% | 120,959 | 1.56B |
| 203 | VRDN | Viridian Therapeutics, Inc. | 3.24B | -1.75% | 3,442,477 | 26.31M |
| 204 | DYN | Dyne Therapeutics, Inc. | 3.24B | -6.36% | 3,210,067 | - |
| 205 | ACHC | Acadia Healthcare Company, Inc. | 3.23B | 7.88% | 5,545,846 | 3.41B |
| 206 | WRBY | Warby Parker Inc. | 3.23B | 22.50% | 11,263,219 | 934.66M |
| 207 | DNLI | Denali Therapeutics Inc. | 3.16B | -5.92% | 2,252,306 | 21.38M |
| 208 | CELC | Celcuity Inc. | 3.13B | -7.51% | 1,425,178 | - |
| 209 | ATRC | AtriCure, Inc. | 3.12B | -6.49% | 980,836 | 589.80M |
| 210 | PRVA | Privia Health Group, Inc. | 3.06B | 6.88% | 3,344,758 | 2.43B |
| 211 | SGRY | Surgery Partners, Inc. | 3.01B | 0.04% | 5,908,251 | 3.37B |
| 212 | AVAH | Aveanna Healthcare Holdings Inc. | 2.98B | -3.94% | 2,326,309 | 2.60B |
| 213 | BHC | Bausch Health Companies Inc. | 2.98B | -4.56% | 3,344,720 | 11.11B |
| 214 | IDYA | IDEAYA Biosciences, Inc. | 2.96B | -5.28% | 1,238,185 | 36.54M |
| 215 | ADMA | ADMA Biologics, Inc. | 2.93B | 26.05% | 15,030,364 | 519.15M |
| 216 | AXGN | Axogen, Inc. | 2.91B | -5.06% | 1,210,607 | 266.93M |
| 217 | ZLAB | Zai Lab Limited | 2.81B | -0.88% | 815,631 | 441.73M |
| 218 | VCEL | Vericel Corporation | 2.65B | 13.85% | 2,685,222 | 324.17M |
| 219 | RGC | Regencell Bioscience Holdings Limited | 2.61B | -2.77% | 180,894 | - |
| 220 | BKD | Brookdale Senior Living Inc. | 2.58B | -3.40% | 9,322,061 | 2.93B |
| 221 | BEAM | Beam Therapeutics Inc. | 2.58B | -6.91% | 2,994,338 | 146.64M |
| 222 | PGNY | Progyny, Inc. | 2.57B | 14.19% | 2,797,466 | 1.34B |
| 223 | XNCR | Xencor, Inc. | 2.56B | -2.80% | 1,434,883 | 200.49M |
| 224 | NEOG | Neogen Corporation | 2.55B | -6.26% | 3,723,517 | 884.00M |
| 225 | RCUS | Arcus Biosciences, Inc. | 2.55B | -8.39% | 2,036,341 | 100.00M |
| 226 | GRDN | Guardian Pharmacy Services, Inc. | 2.53B | -5.27% | 701,199 | 1.46B |
| 227 | HCM | HUTCHMED (China) Limited | 2.47B | 2.01% | 93,109 | 549.12M |
| 228 | MD | Pediatrix Medical Group, Inc. | 2.43B | -2.93% | 905,866 | 1.96B |
| 229 | TMDX | TransMedics Group, Inc. | 2.39B | -5.20% | 1,694,301 | 727.65M |
| 230 | CLOV | Clover Health Investments, Corp. | 2.39B | -4.48% | 8,267,604 | 2.74B |
| 231 | XERS | Xeris Biopharma Holdings, Inc. | 2.38B | 25.05% | 12,640,800 | 368.26M |
| 232 | MBX | MBX Biosciences, Inc. | 2.33B | -7.66% | 428,676 | - |
| 233 | UFPT | UFP Technologies, Inc. | 2.32B | -9.10% | 176,533 | 649.52M |
| 234 | ADUS | Addus HomeCare Corporation | 2.31B | -0.88% | 262,722 | 1.50B |
| 235 | PHVS | Pharvaris N.V. | 2.28B | -5.24% | 934,673 | - |
| 236 | PVLA | Palvella Therapeutics, Inc. | 2.26B | -3.35% | 269,787 | - |
| 237 | NAMS | NewAmsterdam Pharma Company N.V. | 2.26B | -9.75% | 1,564,168 | 25.94M |
| 238 | ARDT | Ardent Health, Inc. | 2.24B | 22.40% | 2,471,501 | 6.45B |
| 239 | CLDX | Celldex Therapeutics, Inc. | 2.22B | -5.55% | 1,113,239 | 158.00K |
| 240 | SEPN | Septerna, Inc. | 2.21B | -1.11% | 534,404 | 98.88M |
| 241 | RXRX | Recursion Pharmaceuticals, Inc. | 2.18B | -9.79% | 25,472,568 | 68.23M |
| 242 | PRGO | Perrigo Company plc | 2.18B | -0.76% | 2,875,543 | 4.09B |
| 243 | AUPH | Aurinia Pharmaceuticals Inc. | 2.17B | -5.26% | 1,140,932 | 321.74M |
| 244 | VERA | Vera Therapeutics, Inc. | 2.17B | -5.72% | 1,422,482 | - |
| 245 | LKFT | Lakefront Biotherapeutics NV | 2.17B | -1.55% | 343,076 | 1.13B |
| 246 | SDGR | Schrödinger, Inc. | 2.16B | 0.88% | 2,221,819 | 269.20M |
| 247 | NEO | NeoGenomics, Inc. | 2.13B | -3.85% | 2,109,354 | 787.75M |
| 248 | COAG | Hemab Therapeutics Holdings, Inc. | 2.13B | 1.06% | 457,004 | - |
| 249 | IMNM | Immunome, Inc. | 2.11B | -8.27% | 2,208,447 | 4.02M |
| 250 | BHVN | Biohaven Ltd. | 2.10B | -8.79% | 3,472,087 | - |
| 251 | PBH | Prestige Consumer Healthcare Inc. | 2.10B | -16.82% | 1,719,274 | 1.17B |
| 252 | TRLV | Trulieve Cannabis Corp. | 2.10B | -6.03% | 1,496,438 | 1.08B |
| 253 | ZYME | Zymeworks Inc. | 2.04B | -7.13% | 1,225,304 | 37.13M |
| 254 | XRAY | DENTSPLY SIRONA Inc. | 2.01B | -5.26% | 7,885,621 | 3.58B |
| 255 | ASTH | Astrana Health, Inc. | 2.00B | -1.66% | 530,342 | 3.84B |
| 256 | FTRE | Fortrea Holdings Inc. | 1.97B | -1.78% | 2,405,591 | 2.67B |
| 257 | MESO | Mesoblast Limited | 1.96B | -1.33% | 261,663 | 120.25M |
| 258 | BCRX | BioCryst Pharmaceuticals, Inc. | 1.95B | -7.40% | 15,370,849 | 961.51M |
| 259 | VCYT | Veracyte, Inc. | 1.93B | -54.30% | 15,003,797 | 581.78M |
| 260 | INSP | Inspire Medical Systems, Inc. | 1.93B | -0.12% | 1,075,299 | 880.94M |
| 261 | ESTA | Establishment Labs Holdings Inc. | 1.92B | -3.76% | 467,244 | 264.03M |
| 262 | WGS | GeneDx Holdings Corp. | 1.92B | -7.18% | 877,874 | 454.43M |
| 263 | AGL | agilon health, inc. | 1.91B | 18.23% | 585,634 | 6.00B |
| 264 | LMAT | LeMaitre Vascular, Inc. | 1.91B | -5.04% | 535,470 | 269.36M |
| 265 | TRAX | First Tracks Biotherapeutics, Inc. | 1.91B | -7.36% | 572,780 | - |
| 266 | HRMY | Harmony Biosciences Holdings, Inc. | 1.91B | -5.67% | 1,481,225 | 989.36M |
| 267 | REPL | Replimune Group, Inc. | 1.90B | -3.24% | 4,006,752 | - |
| 268 | ALMR | Alamar Biosciences, Inc. | 1.87B | -1.77% | 1,239,550 | 114.05M |
| 269 | VIR | Vir Biotechnology, Inc. | 1.86B | -6.37% | 2,939,905 | 302.80M |
| 270 | CERT | Certara, Inc. | 1.86B | 9.83% | 3,738,785 | 412.03M |
| 271 | SRPT | Sarepta Therapeutics, Inc. | 1.86B | -7.48% | 1,873,778 | 1.97B |
| 272 | AMN | AMN Healthcare Services, Inc. | 1.84B | -0.67% | 904,105 | 3.52B |
| 273 | TRVI | Trevi Therapeutics, Inc. | 1.83B | -8.43% | 1,582,609 | - |
| 274 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.81B | -9.59% | 3,215,393 | 213.00M |
| 275 | MAZE | Maze Therapeutics, Inc. | 1.75B | -2.55% | 644,544 | 20.00M |
| 276 | OMCL | Omnicell, Inc. | 1.75B | -3.50% | 785,195 | 1.24B |
| 277 | TDOC | Teladoc Health, Inc. | 1.72B | -2.99% | 10,421,934 | 2.47B |
| 278 | STOK | Stoke Therapeutics, Inc. | 1.71B | -5.03% | 1,219,536 | 28.21M |
| 279 | KMTS | Kestra Medical Technologies, Ltd. | 1.70B | -6.46% | 731,138 | 106.73M |
| 280 | HCSG | Healthcare Services Group, Inc. | 1.69B | -5.39% | 878,320 | 1.88B |
| 281 | ZBIO | Zenas BioPharma, Inc. | 1.69B | -8.89% | 826,226 | 11.00M |
| 282 | AGIO | Agios Pharmaceuticals, Inc. | 1.69B | -9.91% | 2,553,625 | 140.84M |
| 283 | LYCA | Lycia Therapeutics, Inc. | 1.66B | -0.41% | 190,151 | 4.44M |
| 284 | PSNL | Personalis, Inc. | 1.66B | -1.52% | 3,795,810 | 80.77M |
| 285 | ENOV | Enovis Corporation | 1.65B | 17.20% | 5,591,866 | 2.31B |
| 286 | AZTA | Azenta, Inc. | 1.64B | -4.50% | 1,066,996 | 613.81M |
| 287 | ALVO | Alvotech | 1.62B | -2.57% | 753,753 | 494.61M |
| 288 | BFLY | Butterfly Network, Inc. | 1.62B | -10.34% | 6,674,058 | 123.26M |
| 289 | NRIX | Nurix Therapeutics, Inc. | 1.62B | -6.96% | 7,108,138 | 701.94M |
| 290 | SNDA | Sonida Senior Living, Inc. | 1.61B | -7.97% | 1,199,063 | 593.38M |
| 291 | GENB | Generate Biomedicines, Inc. | 1.61B | -11.23% | 1,305,822 | 26.48M |
| 292 | NVAX | Novavax, Inc. | 1.61B | -8.17% | 8,228,048 | 413.80M |
| 293 | ABSI | Absci Corporation | 1.61B | -10.40% | 5,127,857 | 1.56M |
| 294 | SLS | SELLAS Life Sciences Group, Inc. | 1.59B | -13.79% | 10,760,274 | - |
| 295 | NVCR | NovoCure Limited | 1.58B | -7.26% | 1,997,124 | 725.39M |
| 296 | RARE | Ultragenyx Pharmaceutical Inc. | 1.58B | -9.27% | 5,397,992 | 730.00M |
| 297 | ALHC | Alignment Healthcare, Inc. | 1.58B | -7.13% | 4,963,254 | 4.94B |
| 298 | KLRA | Kailera Therapeutics, Inc. | 1.58B | -4.92% | 846,517 | - |
| 299 | CNMD | CONMED Corporation | 1.57B | -1.55% | 406,651 | 1.37B |
| 300 | NBTX | Nanobiotix S.A. | 1.56B | 1.08% | 567,459 | 13.15M |
| 301 | NTLA | Intellia Therapeutics, Inc. | 1.56B | -9.83% | 7,633,052 | 52.89M |
| 302 | PGEN | Precigen, Inc. | 1.51B | -16.52% | 26,715,058 | 156.94M |
| 303 | ANIP | ANI Pharmaceuticals, Inc. | 1.49B | -2.83% | 1,296,847 | 1.04B |
| 304 | ADRX | ADARx Pharmaceuticals, Inc. | 1.49B | -11.16% | 781,210 | 6.13M |
| 305 | NUVB | Nuvation Bio Inc. | 1.47B | -11.42% | 8,424,385 | 201.73M |
| 306 | IMCR | Immunocore Holdings plc | 1.46B | -2.84% | 372,737 | 430.78M |
| 307 | QURE | uniQure N.V. | 1.46B | -8.77% | 5,140,446 | 20.17M |
| 308 | PCRX | Pacira BioSciences, Inc. | 1.45B | 0.05% | 1,132,251 | 743.30M |
| 309 | USPH | U.S. Physical Therapy, Inc. | 1.45B | 8.99% | 309,306 | 829.86M |
| 310 | PAHC | Phibro Animal Health Corporation | 1.44B | -10.22% | 349,216 | 1.54B |
| 311 | TYRA | Tyra Biosciences, Inc. | 1.44B | -2.97% | 696,023 | - |
| 312 | BRVE | Braveheart Bio, Inc. | 1.42B | -13.40% | 1,591,751 | - |
| 313 | AAPG | Ascentage Pharma Group International | 1.42B | 0.40% | 9,846 | 94.61M |
| 314 | OCUL | Ocular Therapeutix, Inc. | 1.41B | -9.94% | 3,134,181 | 52.06M |
| 315 | RAPP | Rapport Therapeutics, Inc. | 1.41B | -8.52% | 707,675 | 20.00M |
| 316 | PNTG | The Pennant Group, Inc. | 1.41B | -9.17% | 1,702,777 | 1.17B |
| 317 | KRSA | Korsana Biosciences, Inc. | 1.39B | -0.43% | 110,235 | - |
| 318 | CRON | Cronos Group Inc. | 1.38B | 5.98% | 3,978,042 | 206.20M |
| 319 | INVA | Innoviva, Inc. | 1.37B | -9.50% | 2,651,571 | 438.32M |
| 320 | ANAB | AnaptysBio, Inc. | 1.36B | -4.06% | 381,621 | 106.09M |
| 321 | GPCR | Structure Therapeutics Inc. | 1.36B | -6.29% | 1,015,106 | - |
| 322 | DMRA | Damora Therapeutics, Inc. | 1.35B | -4.71% | 793,811 | - |
| 323 | ETON | Eton Pharmaceuticals, Inc. | 1.35B | -7.04% | 707,062 | 105.60M |
| 324 | MLYS | Mineralys Therapeutics, Inc. | 1.35B | -10.35% | 2,559,247 | - |
| 325 | STAA | STAAR Surgical Company | 1.34B | -1.66% | 1,453,065 | 328.27M |
| 326 | TSHA | Taysha Gene Therapies, Inc. | 1.33B | -6.19% | 6,749,824 | 5.49M |
| 327 | NUTX | Nutex Health Inc. | 1.33B | -5.64% | 148,440 | 846.72M |
| 328 | OPK | OPKO Health, Inc. | 1.31B | -1.13% | 10,775,934 | 654.10M |
| 329 | KARD | Kardigan, Inc. | 1.30B | -10.93% | 676,387 | - |
| 330 | LMRI | Lumexa Imaging Holdings, Inc. | 1.27B | 0.84% | 486,641 | 1.04B |
| 331 | GHRS | GH Research PLC | 1.27B | -7.48% | 407,733 | - |
| 332 | URGN | UroGen Pharma Ltd. | 1.26B | -10.47% | 2,474,482 | 250.25M |
| 333 | TNDM | Tandem Diabetes Care, Inc. | 1.25B | -5.56% | 3,028,865 | 1.04B |
| 334 | INNV | InnovAge Holding Corp. | 1.24B | -7.15% | 521,601 | 1.02B |
| 335 | OMER | Omeros Corporation | 1.24B | -6.11% | 995,413 | 38.42M |
| 336 | AORT | Artivion, Inc. | 1.23B | -4.23% | 1,127,744 | 471.47M |
| 337 | NKTR | Nektar Therapeutics | 1.23B | -6.06% | 729,449 | 54.59M |
| 338 | LBRX | LB Pharmaceuticals Inc | 1.23B | -6.76% | 354,416 | - |
| 339 | DRTS | Alpha Tau Medical Ltd. | 1.23B | -5.20% | 674,692 | - |
| 340 | ATEC | Alphatec Holdings, Inc. | 1.21B | -5.80% | 4,096,241 | 839.72M |
| 341 | MNKD | MannKind Corporation | 1.21B | -4.33% | 5,413,053 | 393.63M |
| 342 | GDRX | GoodRx Holdings, Inc. | 1.19B | -6.18% | 1,328,700 | 785.23M |
| 343 | SLN | Silence Therapeutics plc | 1.19B | -0.40% | 1,403,764 | 615.00K |
| 344 | AVLN | Avalyn Pharma Inc. | 1.18B | -2.91% | 476,718 | - |
| 345 | INBX | Inhibrx Biosciences, Inc. | 1.18B | -7.47% | 242,518 | 1.30M |
| 346 | AMPH | Amphastar Pharmaceuticals, Inc. | 1.18B | -1.28% | 607,937 | 730.02M |
| 347 | PRCT | PROCEPT BioRobotics Corporation | 1.17B | -6.42% | 3,114,265 | 352.31M |
| 348 | OMDA | Omada Health, Inc. | 1.16B | -2.47% | 2,075,290 | 333.04M |
| 349 | VOR | Vor Biopharma Inc. | 1.15B | -7.26% | 637,073 | - |
| 350 | SGP | SpyGlass Pharma, Inc. | 1.14B | -1.07% | 192,281 | - |
| 351 | VSTM | Verastem, Inc. | 1.14B | -4.77% | 3,054,106 | 100.30M |
| 352 | FRNM | Freenome, Inc. | 1.12B | -7.35% | 1,329,480 | 35.41M |
| 353 | SVRA | Savara Inc. | 1.11B | -6.01% | 3,458,959 | - |
| 354 | AHG | Akso Health Group | 1.11B | -2.63% | 972 | 13.83M |
| 355 | IART | Integra LifeSciences Holdings Corporation | 1.10B | -4.72% | 993,927 | 1.66B |
| 356 | SIBN | SI-BONE, Inc. | 1.09B | -2.73% | 927,142 | 220.65M |
| 357 | IRMD | IRADIMED CORPORATION | 1.09B | -3.43% | 128,034 | 89.34M |
| 358 | SPTX | Seaport Therapeutics, Inc. | 1.09B | -2.72% | 221,060 | - |
| 359 | CMPS | COMPASS Pathways plc | 1.08B | -9.19% | 5,551,816 | - |
| 360 | CSTL | Castle Biosciences, Inc. | 1.04B | -4.34% | 703,002 | 357.28M |
| 361 | CBLL | CeriBell, Inc. | 1.01B | -5.04% | 958,937 | 108.72M |
| 362 | AHCO | AdaptHealth Corp. | 989.90M | 1.37% | 4,633,285 | 3.44B |
| 363 | JANX | Janux Therapeutics, Inc. | 981.86M | -11.66% | 894,502 | 23.29M |
| 364 | HROW | Harrow, Inc. | 976.18M | -9.43% | 702,151 | 275.59M |
| 365 | GMRS | GMR Solutions Inc. | 972.30M | 0.97% | 969,180 | 5.88B |
| 366 | ODTX | Odyssey Therapeutics, Inc. | 934.41M | -3.18% | 434,530 | 99.00K |
| 367 | MLTX | MoonLake Immunotherapeutics | 919.15M | -6.57% | 1,339,123 | - |
| 368 | HSTM | HealthStream, Inc. | 905.64M | -8.87% | 388,093 | 327.95M |
| 369 | BVS | Bioventus Inc. | 899.91M | -6.48% | 807,379 | 585.64M |
| 370 | JBIO | Jade Biosciences, Inc. | 896.72M | -6.25% | 1,288,790 | - |
| 371 | IVA | Inventiva S.A. | 890.92M | -6.20% | 2,537,557 | 2.81M |
| 372 | QDEL | QuidelOrtho Corporation | 880.99M | -10.52% | 4,132,628 | 2.59B |
| 373 | ORIC | ORIC Pharmaceuticals, Inc. | 880.01M | -9.10% | 1,392,694 | - |
| 374 | GLUE | Monte Rosa Therapeutics, Inc. | 874.46M | -5.27% | 1,718,210 | 70.33M |
| 375 | PHAR | Pharming Group N.V. | 868.76M | -1.28% | 12,586 | 386.75M |
| 376 | LTGO | Latigo Biotherapeutics, Inc. | 862.55M | -7.34% | 424,860 | - |
| 377 | ANRO | Alto Neuroscience, Inc. | 858.22M | -6.14% | 411,279 | - |
| 378 | RIGL | Rigel Pharmaceuticals, Inc. | 853.86M | -10.88% | 553,738 | 276.79M |
| 379 | CTY | City Therapeutics, Inc. | 849.35M | 4.02% | 214,645 | 14.34M |
| 380 | IMTX | Immatics N.V. | 844.74M | -10.56% | 1,279,546 | 47.65M |
| 381 | SNDX | Syndax Pharmaceuticals, Inc. | 843.56M | -10.33% | 5,807,361 | 289.68M |
| 382 | BBNX | Beta Bionics, Inc. | 842.15M | -8.61% | 2,078,151 | 127.27M |
| 383 | KIDS | OrthoPediatrics Corp. | 841.28M | -3.85% | 327,565 | 264.14M |
| 384 | AKTS | Aktis Oncology, Inc. | 825.95M | -2.30% | 440,724 | 10.06M |
| 385 | COLL | Collegium Pharmaceutical, Inc. | 819.10M | 6.29% | 1,575,650 | 815.19M |
| 386 | CRVS | Corvus Pharmaceuticals, Inc. | 818.50M | -7.95% | 1,147,602 | - |
| 387 | MGTX | MeiraGTx Holdings plc | 817.33M | -9.66% | 688,570 | 397.50M |
| 388 | BBTX | Bambusa Therapeutics, Inc. | 807.44M | -1.37% | 421,589 | - |
| 389 | PRME | Prime Medicine, Inc. | 791.67M | -10.46% | 4,757,708 | 4.07M |
| 390 | PHR | Phreesia, Inc. | 788.92M | -3.57% | 729,355 | 507.79M |
| 391 | VREX | Varex Imaging Corporation | 777.21M | -0.38% | 640,441 | 865.00M |
| 392 | INMD | InMode Ltd. | 770.24M | -5.63% | 653,461 | 374.63M |
| 393 | ANNX | Annexon, Inc. | 759.26M | -7.51% | 4,367,998 | - |
| 394 | ALMS | Alumis Inc. | 757.20M | -10.69% | 1,953,177 | 7.40M |
| 395 | PACB | Pacific Biosciences of California, Inc. | 755.32M | -4.71% | 20,614,920 | 161.39M |
| 396 | ARDX | Ardelyx, Inc. | 751.60M | -9.12% | 7,777,743 | 468.22M |
| 397 | ABUS | Arbutus Biopharma Corporation | 726.10M | -9.61% | 6,167,643 | 181.72M |
| 398 | LXRX | Lexicon Pharmaceuticals, Inc. | 716.38M | 8.78% | 3,806,336 | 38.54M |
| 399 | CTKB | Cytek Biosciences, Inc. | 706.17M | -8.16% | 1,474,565 | 207.65M |
| 400 | OABI | OmniAb, Inc. | 704.51M | -6.76% | 1,247,517 | 40.21M |
| 401 | SANA | Sana Biotechnology, Inc. | 700.50M | -8.59% | 3,091,371 | - |
| 402 | CGEM | Cullinan Therapeutics, Inc. | 695.03M | -13.53% | 1,792,937 | - |
| 403 | ATTO | Attovia Therapeutics, Inc. | 684.77M | -3.85% | 376,783 | 1.80M |
| 404 | STLN | Starling Oncology, Inc. | 682.84M | -3.46% | 2,083,752 | 587.24M |
| 405 | DNA | Ginkgo Bioworks Holdings, Inc. | 670.71M | -14.51% | 2,374,765 | 132.42M |
| 406 | IRWD | Ironwood Pharmaceuticals, Inc. | 665.92M | 6.90% | 4,999,503 | 400.30M |
| 407 | SLDB | Solid Biosciences Inc. | 662.65M | -5.21% | 1,438,220 | - |
| 408 | AURA | Aura Biosciences, Inc. | 657.49M | -4.66% | 791,414 | - |
| 409 | ACHV | Achieve Life Sciences, Inc. | 656.00M | -8.67% | 1,813,408 | - |
| 410 | SGMT | Sagimet Biosciences Inc. | 646.69M | -8.71% | 1,157,100 | - |
| 411 | WVE | Wave Life Sciences, Inc. | 635.08M | -11.05% | 5,340,957 | 70.92M |
| 412 | ZVRA | Zevra Therapeutics, Inc. | 626.58M | -5.73% | 1,677,424 | 147.76M |
| 413 | ANL | Adlai Nortye Group Ltd. | 623.37M | 0.73% | 450,321 | 18.06M |
| 414 | NVCT | Nuvectis Pharma, Inc. | 622.17M | -3.84% | 340,928 | - |
| 415 | FDMT | 4D Molecular Therapeutics, Inc. | 621.50M | -8.39% | 1,601,078 | 92.01M |
| 416 | EVO | Evotec SE | 616.77M | 13.06% | 274,048 | 815.72M |
| 417 | CADL | Candel Therapeutics, Inc. | 615.21M | -11.16% | 1,229,879 | - |
| 418 | HELP | Helus Pharma Inc. | 612.97M | -3.34% | 1,446,577 | - |
| 419 | GERN | Geron Corporation | 612.09M | -12.03% | 25,872,749 | 217.52M |
| 420 | DBVT | DBV Technologies S.A. | 611.06M | -1.41% | 415,478 | 3.74M |
| 421 | DSGN | Design Therapeutics, Inc. | 605.16M | -9.03% | 752,025 | - |
| 422 | KURA | Kura Oncology, Inc. | 604.93M | -10.64% | 3,621,143 | 77.23M |
| 423 | AVBP | ArriVent BioPharma, Inc. | 603.03M | -9.34% | 1,102,855 | - |
| 424 | MYGN | Myriad Genetics, Inc. | 601.95M | 4.49% | 3,607,453 | 803.60M |
| 425 | IMMX | Immix Biopharma, Inc. | 596.90M | -9.66% | 1,417,228 | - |
| 426 | OBX | Obsidian Therapeutics, Inc. | 593.02M | -12.65% | 779,344 | - |
| 427 | OLMA | Olema Pharmaceuticals, Inc. | 591.48M | -10.34% | 1,706,625 | - |
| 428 | TCMD | Tactile Systems Technology, Inc. | 590.72M | -2.98% | 313,767 | 356.42M |
| 429 | APMD | Apnimed, Inc. | 589.49M | -7.45% | 448,407 | 115.12M |
| 430 | SOPH | SOPHiA GENETICS SA | 567.06M | -5.02% | 759,082 | 90.97M |
| 431 | ACRS | Aclaris Therapeutics, Inc. | 559.49M | -1.90% | 2,331,431 | 6.40M |
| 432 | CBIO | Crescent Biopharma, Inc. | 553.85M | -6.37% | 191,671 | 11.88M |
| 433 | IAM | Iambic Therapeutics, Inc. | 551.75M | -13.13% | 752,658 | 18.25M |
| 434 | VALN | Valneva SE | 544.94M | 0.18% | 5,377 | 163.30M |
| 435 | AVR | Anteris Technologies Global Corp. | 544.01M | -8.82% | 1,894,521 | 2.24M |
| 436 | BCAX | Bicara Therapeutics Inc. | 541.96M | -7.87% | 1,110,170 | - |
| 437 | NRC | NRC Health | 540.72M | -5.87% | 256,216 | 143.79M |
| 438 | SGHT | Sight Sciences, Inc. | 537.66M | 0.83% | 1,074,450 | 88.40M |
| 439 | ENTX | Entera Bio Ltd. | 520.03M | -3.86% | 220,072 | 42.00K |
| 440 | FTH | Faeth Therapeutics, Inc. | 514.74M | -0.35% | 271,245 | - |
| 441 | FLGT | Fulgent Genetics, Inc. | 513.44M | -5.18% | 388,778 | 323.93M |
| 442 | SLBT | SL Science Holding Limited | 513.30M | -18.91% | 142,357 | 3.27M |
| 443 | NGNE | Neurogene Inc. | 513.29M | -7.00% | 382,212 | 925.00K |
| 444 | EVH | Evolent Health, Inc. | 513.29M | -5.42% | 3,500,129 | 2.34B |
| 445 | CLYM | Climb Bio, Inc. | 509.46M | -4.93% | 1,438,545 | - |
| 446 | YDES | YD Bio Limited | 508.57M | 3.31% | 77,017 | 1.24M |
| 447 | SRZN | Surrozen, Inc. | 507.36M | -8.37% | 220,412 | 11.51M |
| 448 | PBYI | Puma Biotechnology, Inc. | 504.33M | -8.61% | 491,550 | 231.24M |
| 449 | MCTA | Charming Medical Limited | 504.26M | -0.02% | - | 4.81M |
| 450 | OVID | Ovid Therapeutics Inc. | 503.87M | -5.84% | 2,018,901 | 1.58M |
| 451 | DCTH | Delcath Systems, Inc. | 502.79M | -2.23% | 554,938 | 95.42M |
| 452 | CAPR | Capricor Therapeutics, Inc. | 500.00M | -3.59% | 4,721,398 | 11.13M |
| 453 | ANGO | AngioDynamics, Inc. | 496.66M | -3.59% | 488,971 | 325.38M |
| 454 | DMAC | DiaMedica Therapeutics Inc. | 487.49M | -16.06% | 330,862 | - |
| 455 | RGNX | REGENXBIO Inc. | 487.18M | -4.28% | 1,679,423 | 153.91M |
| 456 | TKNO | Alpha Teknova, Inc. | 486.22M | 6.92% | 1,066,319 | 45.95M |
| 457 | INDP | Indaptus Therapeutics, Inc. | 485.32M | -4.24% | 204,620 | - |
| 458 | RCEL | AVITA Medical, Inc. | 484.93M | -3.92% | 714,178 | 75.63M |
| 459 | MDXG | MiMedx Group, Inc. | 478.64M | 2.50% | 2,844,923 | 303.73M |
| 460 | SENS | Senseonics Holdings, Inc. | 476.92M | -11.42% | 797,838 | 48.55M |
| 461 | SRTA | Strata Critical Medical, Inc. | 469.82M | 0.77% | 1,734,829 | 280.76M |
| 462 | CTMX | CytomX Therapeutics, Inc. | 466.30M | -8.94% | 3,873,532 | 18.30M |
| 463 | ETRA | Electra Therapeutics, Inc. | 461.34M | -7.78% | 529,524 | - |
| 464 | AQST | Aquestive Therapeutics, Inc. | 460.02M | -3.68% | 3,260,670 | 48.84M |
| 465 | MNPR | Monopar Therapeutics Inc. | 451.19M | -7.68% | 157,657 | - |
| 466 | STTK | Shattuck Labs, Inc. | 450.63M | -12.82% | 1,436,090 | 1.00M |
| 467 | EOLS | Evolus, Inc. | 449.44M | -9.04% | 2,132,292 | 325.47M |
| 468 | BWAY | BrainsWay Ltd. | 441.01M | -5.35% | 92,067 | 60.70M |
| 469 | NPCE | NeuroPace, Inc. | 435.58M | -4.87% | 122,288 | 106.99M |
| 470 | EPRX | Eupraxia Pharmaceuticals Inc. | 434.76M | -2.37% | 791,003 | - |
| 471 | TLRY | Tilray Brands, Inc. | 434.12M | -5.07% | 6,748,816 | 963.10M |
| 472 | CERS | Cerus Corporation | 430.16M | -11.80% | 2,457,938 | 226.57M |
| 473 | ARVN | Arvinas, Inc. | 428.93M | -11.73% | 1,263,355 | 275.30M |
| 474 | GYRE | Gyre Therapeutics, Inc. | 425.20M | -9.68% | 266,784 | 109.82M |
| 475 | SI | Shoulder Innovations, Inc. | 424.08M | -3.05% | 121,325 | 60.06M |
| 476 | OCS | Oculis Holding AG | 421.63M | -6.18% | 372,880 | 1.12M |
| 477 | MASS | 908 Devices Inc. | 419.54M | -8.31% | 476,674 | 60.84M |
| 478 | CARL | Carlsmed, Inc. | 418.28M | -4.79% | 99,622 | 63.30M |
| 479 | CRMD | CorMedix Inc. | 407.65M | -7.60% | 1,835,132 | 462.25M |
| 480 | ASMB | Assembly Biosciences, Inc. | 407.21M | 0.65% | 519,951 | 74.85M |
| 481 | PRTA | Prothena Corporation plc | 405.05M | -5.96% | 519,617 | 54.53M |
| 482 | PHAT | Phathom Pharmaceuticals, Inc. | 403.50M | -10.56% | 1,554,190 | 274.88M |
| 483 | RLMD | Relmada Therapeutics, Inc. | 402.15M | -9.59% | 1,488,945 | - |
| 484 | BLSM | BlossomHill Therapeutics, Inc. | 392.54M | -0.24% | 351,852 | - |
| 485 | EDIT | Editas Medicine, Inc. | 391.63M | -6.25% | 2,101,464 | 47.01M |
| 486 | KMDA | Kamada Ltd. | 388.42M | -7.41% | 257,657 | 191.85M |
| 487 | ALT | Altimmune, Inc. | 383.20M | -7.08% | 4,210,208 | 31.00K |
| 488 | RZLT | Rezolute, Inc. | 381.82M | -8.08% | 1,231,493 | - |
| 489 | SSII | SS Innovations International, Inc. | 380.73M | -16.30% | 140,601 | 52.40M |
| 490 | TECX | Tectonic Therapeutic, Inc. | 379.65M | -4.33% | 109,787 | - |
| 491 | ALLO | Allogene Therapeutics, Inc. | 376.59M | -8.40% | 15,300,712 | 4.64M |
| 492 | MOBI | Mobia Medical, Inc. | 375.52M | 0.36% | 183,833 | 45.28M |
| 493 | LYEL | Lyell Immunopharma, Inc. | 367.58M | -2.79% | 658,854 | 15.00K |
| 494 | PRLD | Prelude Therapeutics Incorporated | 366.15M | -12.87% | 208,784 | 22.42M |
| 495 | OFIX | Orthofix Medical Inc. | 363.33M | -8.23% | 1,366,102 | 833.19M |
| 496 | CCCC | C4 Therapeutics, Inc. | 362.92M | -5.45% | 3,688,970 | 32.28M |
| 497 | EMBC | Embecta Corp. | 358.66M | -2.91% | 780,919 | 1.02B |
| 498 | ZURA | Zura Bio Limited | 358.33M | -7.46% | 2,660,304 | - |
| 499 | AVTX | Avalo Therapeutics, Inc. | 355.57M | -6.22% | 1,259,660 | 59.00K |
| 500 | TRXB | TRex Bio, Inc. | 349.72M | -4.13% | 170,461 | - |